B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CDK5R1

MOLECULAR TARGET

cyclin dependent kinase 5 regulatory subunit 1

UniProt: Q15078NCBI Gene: 88519 compounds

CDK5R1 (cyclin dependent kinase 5 regulatory subunit 1) is targeted by 9 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CDK5R1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1kenpaullone2.208
2indirubin1.956
3alsterpaullone1.795
4Apigenin 5,7,4'-trihydroxy-flavone,1.102
5chrysin1.102
6fisetin1.102
7Luteolin 5,7,3',4'-tetrahydroxy-flavone,1.102
8Harmine Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is1.102
9egcg0.691

About CDK5R1 as a Drug Target

CDK5R1 (cyclin dependent kinase 5 regulatory subunit 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 9 compounds with documented CDK5R1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CDK5R1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.